Holen Sie sich die Stockscreener-App
0.00
100.00%
-4.26
Checkpoint Therapeutics Inc Aktie (CKPT) Neueste Nachrichten
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Shares Bought by Bank of America Corp DE - Defense World
54,186 Shares in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Acquired by Millennium Management LLC - Defense World
Two Sigma Investments LP Grows Stock Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Squarepoint Ops LLC Purchases Shares of 71,938 Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Wealth Enhancement Advisory Services LLC Has $1.36 Million Stock Position in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Northern Trust Corp Purchases 10,232 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics, Inc.(NasdaqCM: CKPT) dropped from S&P TMI Index - marketscreener.com
Checkpoint Therapeutics Completes Merger with Sun Pharma Subsidiary - MSN
Sun Pharma concludes acquisition of Checkpoint Therapeutics - Medical Dialogues
Sun Pharma Finalizes $416M Deal for Checkpoint Therapeutics, Inc. (CKPT) - Insider Monkey
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpo - GuruFocus
Checkpoint Therapeutics finalizes acquisition by Sun Pharma - Investing.com Nigeria
Sun Pharma Completes its Acquisition of Checkpoint Therapeutics - citybiz
Sun Pharma completes its acquisition of Checkpoint Therapeutics - Moneycontrol
Fortress Biotech Announces Sale of Subsidiary Checkpoint Therapeutics - citybiz
Sun Pharmaceutical Industries Completes Acquisition Of Checkpoint Therapeutics - marketscreener.com
Fortress Biotech Closes Sale of Checkpoint Therapeutics Unit - marketscreener.com
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - The Manila Times
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics | FBIO Stock News - GuruFocus
Fortress Biotech, Inc. Announces Acquisition of Checkpoint Therapeutics by Sun Pharmaceutical Industries Limited - Nasdaq
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - Benzinga
Fortress Biotech Cashes In: $28M Upfront Plus Royalties in Strategic Checkpoint Sale to Sun Pharma - Stock Titan
Checkpoint Therapeutics finalizes acquisition by Sun Pharma By Investing.com - Investing.com South Africa
Checkpoint Therapeutics shareholders approve Sun Pharma merger By Investing.com - Investing.com India
Checkpoint Therapeutics shareholders approve Sun Pharma merger - Investing.com
Checkpoint Therapeutics Approves Merger with Sun Pharma - TipRanks
D. E. Shaw & Co. Inc. Has $95,000 Position in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics, Inc. (CKPT) Stock Analysis: Is There More Room to Grow Beyond Its 2.44% Potential Upside? - DirectorsTalk Interviews
Checkpoint Pharma Sued Over Controversial $355M Merger - USA Herald
Checkpoint Investor Sues for Info on Sale From Fortress to Sun - Bloomberg Law News
Checkpoint Therapeutics Reports Q1 2025 Financials and Updates - TipRanks
Checkpoint Therapeutics Announces Merger Progress By Investing.com - Investing.com Canada
Checkpoint Therapeutics Announces Merger Progress - Investing.com
Checkpoint Therapeutics Merger Awaits Stockholder Vote - TipRanks
Cancer Drug Co. Beats Investor Suit Over FDA Rejection - Law360
Checkpoint Therapeutics Beats Investor Suit Over FDA Assent (1) - Bloomberg Law News
Balyasny Asset Management L.P. Buys New Stake in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Stifel Financial Corp Acquires New Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Fortress Biotech Earnings: Triple Win with $28M Checkpoint Deal, FDA Fast-Track, and Rosacea Drug Launch - Stock Titan
Lake Street Keeps Their Hold Rating on Checkpoint Therapeutics (CKPT) - The Globe and Mail
Tower Research Capital LLC TRC Acquires 6,486 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates - GlobeNewswire
Checkpoint Therapeutics Secures $416M Merger Deal After Landmark FDA Cancer Drug Approval - Stock Titan
Envestnet Asset Management Inc. Has $214,000 Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Tecsys Placed as a Challenger in 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems - The Globe and Mail
Marshall Wace LLP Decreases Stake in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics (CKPT) Expected to Announce Earnings on Friday - Defense World
Microsoft’s Stock Rises 9% As Financial Results Top Estimates - The Globe and Mail
CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc.CKPT - marketscreener.com
5.12%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):